×

Stocks Johnson & Johnson

  • Stocks ended mostly lower Tuesday after J&J's revenue miss stirred worries about this earnings season.

  • earnings_central_badge.jpg

    Railroad company CSX releases its third-quarter earnings Tuesday, but Donald Broughton, transportation analyst at Avondale Partners, said he wouldn't buy into the company at its current levels because of lower volumes and pricing risks associated with railroads.

  • The Fast Money traders are closely watching Intel calling this stock is a major ‘tell’ not only for tech but the broad market. What must you know?

  • Dow component Johnson & Johnson—the first major health care company to report earnings this quarter—posted weaker-than-expected quarterly revenue on Tuesday. Mike Weinstein, managing director and senior medical technology analyst at JPMorgan, offered his analysis of JNJ.

  • Stocks skidded Tuesday as earnings season took a turn for the worse. After a few companies delivered what analysts want to see this quarter, improvement in revenue, J&J delivered more of the same from last quarter.

  • Dollar index breaking through to new lows as gold hits another high, most commodities also up 1 to 3 percent. Gold stocks up 2 to 3 percent pre-open.

  • Futures indicated a lower open for Wall Street on Tuesday, after the U.S. market's record-making day on Monday where the Dow Industrial Average reached a new 2009 trading high, close to the 10,000 mark.

  • What follows is a roundup of corporate earnings reports for Tuesday, Oct. 13.

  • Risky assets will continue to outperform safer assets and investors should stick to bonds and quality stocks such as Johnson & Johnson, Intel and CSX, instead of Treasurys and cash, Bob Doll, vice chairman and global CIO of equities at BlackRock, told CNBC.

  • A New York Stock Exchange trader.

    The positive side of the weak greenback story should show up this week, as a parade of multinationals report earnings.

  • Stocks shot out of the gate Monday, fueled by earnings optimism, but then pulled back near the final hour of trading as investors took some profits.

  • Going by historical precedent and recent chart strength, Johnson & Johnson leads a list of companies most likely to beat Street estimates and subsequently trade higher.

  • Two and a half months away from the end of the year and the average dividend yield of the Dow 30 has continued to fall since the market lows.  See how the 30 companies in the Dow compare.

  • MM_promo_Cramerica_Challenge_530x50.jpg

    A “ton of upside” is in store for this stock, Cramer says. Find out why.

  • MM_promo_Cramerica_Challenge_530x50.jpg

    It’s all about the earnings, he says. These are the companies you need to watch.

  • The global recovery is being led by countries outside of the United States, and investors should look to multinational corporations to protect themselves against the weakening dollar, said David Darst of Morgan Stanley Smith Barney.

  • Following are the week’s biggest winners and losers. Find out why shares of Newmont and Wells Fargo popped while Acorda Therap. and the iShares 20 Year Treas. ETF  dropped.

  • The S&P 500 is up 4 percent this week, it's best gain in a long time, and it's a simple story: Alcoa and a number of retailers are all signaling that the economy is slowly improving, and for the moment "slowly" is good enough for the stock market.

  • Can the bulls can generate enough momentum to drive the Dow over 10,000 next week, or are they're about to be sidelined by the dollar?

  • alcoa1_new.jpg

    Third-quarter earnings got off to a positive start with Alcoa's surprising profit, but investors will be watching corporate results closely to see if they justify a continued stock market rally.